DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups

Hemangioblastomas (HBs) of the central nervous system are highly vascular neoplasms that occur sporadically or as a manifestation of von Hippel–Lindau (VHL) disease. Despite their benign nature, HBs are clinically heterogeneous and can be associated with significant morbidity due to mass effects of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain pathology (Zurich, Switzerland) Switzerland), 2022-11, Vol.32 (6), p.e13083-n/a
Hauptverfasser: Woltering, Niklas, Albers, Anne, Müther, Michael, Stummer, Walter, Paulus, Werner, Hasselblatt, Martin, Holling, Markus, Thomas, Christian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 6
container_start_page e13083
container_title Brain pathology (Zurich, Switzerland)
container_volume 32
creator Woltering, Niklas
Albers, Anne
Müther, Michael
Stummer, Walter
Paulus, Werner
Hasselblatt, Martin
Holling, Markus
Thomas, Christian
description Hemangioblastomas (HBs) of the central nervous system are highly vascular neoplasms that occur sporadically or as a manifestation of von Hippel–Lindau (VHL) disease. Despite their benign nature, HBs are clinically heterogeneous and can be associated with significant morbidity due to mass effects of peritumoral cysts or tumor progression. Underlying molecular factors involved in HB tumor biology remain elusive. We investigated genome‐wide DNA methylation profiles and clinical and histopathological features in a series of 47 HBs from 42 patients, including 28 individuals with VHL disease. Thirty tumors occurred in the cerebellum, 8 in the brainstem and 8 HBs were of spinal location, while 1 HB was located in the cerebrum. Histologically, 12 HBs (26%) belonged to the cellular subtype and exclusively occurred in the cerebellum, whereas 35 HBs were reticular (74%). Unsupervised clustering and dimensionality reduction of DNA methylation profiles revealed two distinct subgroups. Methylation cluster 1 comprised 30 HBs of mainly cerebellar location (29/30, 97%), whereas methylation cluster 2 contained 17 HBs predominantly located in non‐cerebellar compartments (16/17, 94%). The sum of chromosomal regions being affected by copy‐number alterations was significantly higher in methylation cluster 1 compared to cluster 2 (mean 262 vs. 109 Mb, p = 0.001). Of note, loss of chromosome 6 occurred in 9/30 tumors (30%) of methylation cluster 1 and was not observed in cluster 2 tumors (p = 0.01). No relevant methylation differences between sporadic and VHL‐related HBs or cystic and non‐cystic HBs could be detected. Deconvolution of the bulk DNA methylation profiles revealed four methylation components that were associated with the two methylation clusters suggesting cluster‐specific cell‐type compositions. In conclusion, methylation profiling of HBs reveals 2 distinct subgroups that mainly associate with anatomical location, cytogenetic profiles and differences in cell type composition, potentially reflecting different cells of origin.
doi_str_mv 10.1111/bpa.13083
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9616087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2672327759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3733-872cdc87b406401ffc02b19f86f0e73f36f492e3c193a80e01127584e6faa49f3</originalsourceid><addsrcrecordid>eNp1kU2PFCEQhonRuOvqwT9gSLzooXeB6obmYjKun8lGPeiZ0Az0sOmGFujdzL8XnXGjJnIpknrypKpehJ5Sck7ruxgWfU6B9HAPnVLRkQY4yPv1T2jXcCDdCXqU8zUhVHLZPUQn0HEQnPFTNL75tMGzLbv9pIuPAS8pOj_5MOLosLGhJD3hYNNNXDPO-1zsjHd21mH0cZh0LnHWGfttJb3zNuNyG_HW5-KDKTivw5jiuuTH6IHTU7ZPjvUMfXv39uvlh-bq8_uPl5urxoAAaHrBzNb0YmgJbwl1zhA2UOl67ogV4IC7VjILhkrQPbGEUia6vrXcad1KB2fo1cG7rMNst8cF1JL8rNNeRe3V353gd2qMN0pyykkvquDFUZDi99XmomafjZ0mHWw9gWJcMGBCdLKiz_9Br-OaQl1PMcFkBxIoq9TLA2VSzDlZdzcMJepnfKrGp37FV9lnf05_R_7OqwIXB-DWT3b_f5N6_WVzUP4A9Vymdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2729539312</pqid></control><display><type>article</type><title>DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups</title><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Woltering, Niklas ; Albers, Anne ; Müther, Michael ; Stummer, Walter ; Paulus, Werner ; Hasselblatt, Martin ; Holling, Markus ; Thomas, Christian</creator><creatorcontrib>Woltering, Niklas ; Albers, Anne ; Müther, Michael ; Stummer, Walter ; Paulus, Werner ; Hasselblatt, Martin ; Holling, Markus ; Thomas, Christian</creatorcontrib><description>Hemangioblastomas (HBs) of the central nervous system are highly vascular neoplasms that occur sporadically or as a manifestation of von Hippel–Lindau (VHL) disease. Despite their benign nature, HBs are clinically heterogeneous and can be associated with significant morbidity due to mass effects of peritumoral cysts or tumor progression. Underlying molecular factors involved in HB tumor biology remain elusive. We investigated genome‐wide DNA methylation profiles and clinical and histopathological features in a series of 47 HBs from 42 patients, including 28 individuals with VHL disease. Thirty tumors occurred in the cerebellum, 8 in the brainstem and 8 HBs were of spinal location, while 1 HB was located in the cerebrum. Histologically, 12 HBs (26%) belonged to the cellular subtype and exclusively occurred in the cerebellum, whereas 35 HBs were reticular (74%). Unsupervised clustering and dimensionality reduction of DNA methylation profiles revealed two distinct subgroups. Methylation cluster 1 comprised 30 HBs of mainly cerebellar location (29/30, 97%), whereas methylation cluster 2 contained 17 HBs predominantly located in non‐cerebellar compartments (16/17, 94%). The sum of chromosomal regions being affected by copy‐number alterations was significantly higher in methylation cluster 1 compared to cluster 2 (mean 262 vs. 109 Mb, p = 0.001). Of note, loss of chromosome 6 occurred in 9/30 tumors (30%) of methylation cluster 1 and was not observed in cluster 2 tumors (p = 0.01). No relevant methylation differences between sporadic and VHL‐related HBs or cystic and non‐cystic HBs could be detected. Deconvolution of the bulk DNA methylation profiles revealed four methylation components that were associated with the two methylation clusters suggesting cluster‐specific cell‐type compositions. In conclusion, methylation profiling of HBs reveals 2 distinct subgroups that mainly associate with anatomical location, cytogenetic profiles and differences in cell type composition, potentially reflecting different cells of origin.</description><identifier>ISSN: 1015-6305</identifier><identifier>EISSN: 1750-3639</identifier><identifier>DOI: 10.1111/bpa.13083</identifier><identifier>PMID: 35637626</identifier><language>eng</language><publisher>Switzerland: John Wiley &amp; Sons, Inc</publisher><subject>Brain stem ; Central nervous system ; Cerebellum ; Cerebrum ; Chromosome 6 ; Clustering ; Composition ; Cysts ; Cytogenetics ; Deoxyribonucleic acid ; DNA ; DNA fingerprinting ; DNA methylation ; Genomes ; hemangioblastoma ; methylation profiling ; Morbidity ; Neoplasms ; Nervous system ; Subgroups ; Tumors ; Vein &amp; artery diseases ; VHL protein ; Von Hippel-Lindau disease</subject><ispartof>Brain pathology (Zurich, Switzerland), 2022-11, Vol.32 (6), p.e13083-n/a</ispartof><rights>2022 The Authors. published by John Wiley &amp; Sons Ltd on behalf of International Society of Neuropathology.</rights><rights>2022 The Authors. Brain Pathology published by John Wiley &amp; Sons Ltd on behalf of International Society of Neuropathology.</rights><rights>2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3733-872cdc87b406401ffc02b19f86f0e73f36f492e3c193a80e01127584e6faa49f3</citedby><cites>FETCH-LOGICAL-c3733-872cdc87b406401ffc02b19f86f0e73f36f492e3c193a80e01127584e6faa49f3</cites><orcidid>0000-0003-2707-8484 ; 0000-0002-6642-7774</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616087/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616087/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35637626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Woltering, Niklas</creatorcontrib><creatorcontrib>Albers, Anne</creatorcontrib><creatorcontrib>Müther, Michael</creatorcontrib><creatorcontrib>Stummer, Walter</creatorcontrib><creatorcontrib>Paulus, Werner</creatorcontrib><creatorcontrib>Hasselblatt, Martin</creatorcontrib><creatorcontrib>Holling, Markus</creatorcontrib><creatorcontrib>Thomas, Christian</creatorcontrib><title>DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups</title><title>Brain pathology (Zurich, Switzerland)</title><addtitle>Brain Pathol</addtitle><description>Hemangioblastomas (HBs) of the central nervous system are highly vascular neoplasms that occur sporadically or as a manifestation of von Hippel–Lindau (VHL) disease. Despite their benign nature, HBs are clinically heterogeneous and can be associated with significant morbidity due to mass effects of peritumoral cysts or tumor progression. Underlying molecular factors involved in HB tumor biology remain elusive. We investigated genome‐wide DNA methylation profiles and clinical and histopathological features in a series of 47 HBs from 42 patients, including 28 individuals with VHL disease. Thirty tumors occurred in the cerebellum, 8 in the brainstem and 8 HBs were of spinal location, while 1 HB was located in the cerebrum. Histologically, 12 HBs (26%) belonged to the cellular subtype and exclusively occurred in the cerebellum, whereas 35 HBs were reticular (74%). Unsupervised clustering and dimensionality reduction of DNA methylation profiles revealed two distinct subgroups. Methylation cluster 1 comprised 30 HBs of mainly cerebellar location (29/30, 97%), whereas methylation cluster 2 contained 17 HBs predominantly located in non‐cerebellar compartments (16/17, 94%). The sum of chromosomal regions being affected by copy‐number alterations was significantly higher in methylation cluster 1 compared to cluster 2 (mean 262 vs. 109 Mb, p = 0.001). Of note, loss of chromosome 6 occurred in 9/30 tumors (30%) of methylation cluster 1 and was not observed in cluster 2 tumors (p = 0.01). No relevant methylation differences between sporadic and VHL‐related HBs or cystic and non‐cystic HBs could be detected. Deconvolution of the bulk DNA methylation profiles revealed four methylation components that were associated with the two methylation clusters suggesting cluster‐specific cell‐type compositions. In conclusion, methylation profiling of HBs reveals 2 distinct subgroups that mainly associate with anatomical location, cytogenetic profiles and differences in cell type composition, potentially reflecting different cells of origin.</description><subject>Brain stem</subject><subject>Central nervous system</subject><subject>Cerebellum</subject><subject>Cerebrum</subject><subject>Chromosome 6</subject><subject>Clustering</subject><subject>Composition</subject><subject>Cysts</subject><subject>Cytogenetics</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA fingerprinting</subject><subject>DNA methylation</subject><subject>Genomes</subject><subject>hemangioblastoma</subject><subject>methylation profiling</subject><subject>Morbidity</subject><subject>Neoplasms</subject><subject>Nervous system</subject><subject>Subgroups</subject><subject>Tumors</subject><subject>Vein &amp; artery diseases</subject><subject>VHL protein</subject><subject>Von Hippel-Lindau disease</subject><issn>1015-6305</issn><issn>1750-3639</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU2PFCEQhonRuOvqwT9gSLzooXeB6obmYjKun8lGPeiZ0Az0sOmGFujdzL8XnXGjJnIpknrypKpehJ5Sck7ruxgWfU6B9HAPnVLRkQY4yPv1T2jXcCDdCXqU8zUhVHLZPUQn0HEQnPFTNL75tMGzLbv9pIuPAS8pOj_5MOLosLGhJD3hYNNNXDPO-1zsjHd21mH0cZh0LnHWGfttJb3zNuNyG_HW5-KDKTivw5jiuuTH6IHTU7ZPjvUMfXv39uvlh-bq8_uPl5urxoAAaHrBzNb0YmgJbwl1zhA2UOl67ogV4IC7VjILhkrQPbGEUia6vrXcad1KB2fo1cG7rMNst8cF1JL8rNNeRe3V353gd2qMN0pyykkvquDFUZDi99XmomafjZ0mHWw9gWJcMGBCdLKiz_9Br-OaQl1PMcFkBxIoq9TLA2VSzDlZdzcMJepnfKrGp37FV9lnf05_R_7OqwIXB-DWT3b_f5N6_WVzUP4A9Vymdg</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Woltering, Niklas</creator><creator>Albers, Anne</creator><creator>Müther, Michael</creator><creator>Stummer, Walter</creator><creator>Paulus, Werner</creator><creator>Hasselblatt, Martin</creator><creator>Holling, Markus</creator><creator>Thomas, Christian</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>M7S</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2707-8484</orcidid><orcidid>https://orcid.org/0000-0002-6642-7774</orcidid></search><sort><creationdate>202211</creationdate><title>DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups</title><author>Woltering, Niklas ; Albers, Anne ; Müther, Michael ; Stummer, Walter ; Paulus, Werner ; Hasselblatt, Martin ; Holling, Markus ; Thomas, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3733-872cdc87b406401ffc02b19f86f0e73f36f492e3c193a80e01127584e6faa49f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Brain stem</topic><topic>Central nervous system</topic><topic>Cerebellum</topic><topic>Cerebrum</topic><topic>Chromosome 6</topic><topic>Clustering</topic><topic>Composition</topic><topic>Cysts</topic><topic>Cytogenetics</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA fingerprinting</topic><topic>DNA methylation</topic><topic>Genomes</topic><topic>hemangioblastoma</topic><topic>methylation profiling</topic><topic>Morbidity</topic><topic>Neoplasms</topic><topic>Nervous system</topic><topic>Subgroups</topic><topic>Tumors</topic><topic>Vein &amp; artery diseases</topic><topic>VHL protein</topic><topic>Von Hippel-Lindau disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Woltering, Niklas</creatorcontrib><creatorcontrib>Albers, Anne</creatorcontrib><creatorcontrib>Müther, Michael</creatorcontrib><creatorcontrib>Stummer, Walter</creatorcontrib><creatorcontrib>Paulus, Werner</creatorcontrib><creatorcontrib>Hasselblatt, Martin</creatorcontrib><creatorcontrib>Holling, Markus</creatorcontrib><creatorcontrib>Thomas, Christian</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Brain pathology (Zurich, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woltering, Niklas</au><au>Albers, Anne</au><au>Müther, Michael</au><au>Stummer, Walter</au><au>Paulus, Werner</au><au>Hasselblatt, Martin</au><au>Holling, Markus</au><au>Thomas, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups</atitle><jtitle>Brain pathology (Zurich, Switzerland)</jtitle><addtitle>Brain Pathol</addtitle><date>2022-11</date><risdate>2022</risdate><volume>32</volume><issue>6</issue><spage>e13083</spage><epage>n/a</epage><pages>e13083-n/a</pages><issn>1015-6305</issn><eissn>1750-3639</eissn><abstract>Hemangioblastomas (HBs) of the central nervous system are highly vascular neoplasms that occur sporadically or as a manifestation of von Hippel–Lindau (VHL) disease. Despite their benign nature, HBs are clinically heterogeneous and can be associated with significant morbidity due to mass effects of peritumoral cysts or tumor progression. Underlying molecular factors involved in HB tumor biology remain elusive. We investigated genome‐wide DNA methylation profiles and clinical and histopathological features in a series of 47 HBs from 42 patients, including 28 individuals with VHL disease. Thirty tumors occurred in the cerebellum, 8 in the brainstem and 8 HBs were of spinal location, while 1 HB was located in the cerebrum. Histologically, 12 HBs (26%) belonged to the cellular subtype and exclusively occurred in the cerebellum, whereas 35 HBs were reticular (74%). Unsupervised clustering and dimensionality reduction of DNA methylation profiles revealed two distinct subgroups. Methylation cluster 1 comprised 30 HBs of mainly cerebellar location (29/30, 97%), whereas methylation cluster 2 contained 17 HBs predominantly located in non‐cerebellar compartments (16/17, 94%). The sum of chromosomal regions being affected by copy‐number alterations was significantly higher in methylation cluster 1 compared to cluster 2 (mean 262 vs. 109 Mb, p = 0.001). Of note, loss of chromosome 6 occurred in 9/30 tumors (30%) of methylation cluster 1 and was not observed in cluster 2 tumors (p = 0.01). No relevant methylation differences between sporadic and VHL‐related HBs or cystic and non‐cystic HBs could be detected. Deconvolution of the bulk DNA methylation profiles revealed four methylation components that were associated with the two methylation clusters suggesting cluster‐specific cell‐type compositions. In conclusion, methylation profiling of HBs reveals 2 distinct subgroups that mainly associate with anatomical location, cytogenetic profiles and differences in cell type composition, potentially reflecting different cells of origin.</abstract><cop>Switzerland</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>35637626</pmid><doi>10.1111/bpa.13083</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-2707-8484</orcidid><orcidid>https://orcid.org/0000-0002-6642-7774</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1015-6305
ispartof Brain pathology (Zurich, Switzerland), 2022-11, Vol.32 (6), p.e13083-n/a
issn 1015-6305
1750-3639
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9616087
source Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Brain stem
Central nervous system
Cerebellum
Cerebrum
Chromosome 6
Clustering
Composition
Cysts
Cytogenetics
Deoxyribonucleic acid
DNA
DNA fingerprinting
DNA methylation
Genomes
hemangioblastoma
methylation profiling
Morbidity
Neoplasms
Nervous system
Subgroups
Tumors
Vein & artery diseases
VHL protein
Von Hippel-Lindau disease
title DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A52%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DNA%20methylation%20profiling%20of%20central%20nervous%20system%20hemangioblastomas%20identifies%20two%20distinct%20subgroups&rft.jtitle=Brain%20pathology%20(Zurich,%20Switzerland)&rft.au=Woltering,%20Niklas&rft.date=2022-11&rft.volume=32&rft.issue=6&rft.spage=e13083&rft.epage=n/a&rft.pages=e13083-n/a&rft.issn=1015-6305&rft.eissn=1750-3639&rft_id=info:doi/10.1111/bpa.13083&rft_dat=%3Cproquest_pubme%3E2672327759%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2729539312&rft_id=info:pmid/35637626&rfr_iscdi=true